FFO
KOD icon

Fortitude Family Office’s Kodiak Sciences KOD Stock Holding History

Fortitude Family Office’s Portfolio KOD Stock Details KOD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.96K Buy
76
+31
+69% +$1.21K ﹤0.01% 1315
2026
Q1 		$1.72K Buy
+45
New +$1.16K ﹤0.01% 1335

Other funds holding KOD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Fortitude Family Office's KOD Position: Q2 2026 in Review

Fortitude Family Office increased its Kodiak Sciences (KOD) stake by 69% in Q2 2026, buying an estimated $1.21K and bringing the position to 76 shares worth $2.96K. The position accounts for ﹤0.01% of the portfolio, ranked #1315.

Fortitude Family Office first reported a position in KOD in Q1 2026 and has held it in 2 quarters since. 200 funds tracked by Wall St. Rank hold KOD as of Q2 2026.

  • Fortitude Family Office held 76 shares of Kodiak Sciences worth $2.96K as of Q2 2026.
  • Fortitude Family Office bought 31 Kodiak Sciences shares in Q2 2026, an estimated $1.21K.
  • Kodiak Sciences made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #1315 holding.
  • Fortitude Family Office first reported a position in Kodiak Sciences in Q1 2026 and has held it in 2 quarters since.
  • 200 funds tracked by Wall St. Rank held Kodiak Sciences as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.